An interesting study in the works is the investigation of Immunoglobulin Y (IgY) technology as a source for reagents in infectious disease diagnostics. Little is known about IgY technology, and IMBB fully realizes its potential applications for both human and veterinary medicine. Target infectious diseases that will be worked on are Dengue, Malaria, Salmonella, Tuberculosis and Chlamydia. In the future, it is expected that a wider range of diseases will be able to utilize the fruits of this exploration.

Current molecular testing for the diagnosis of infectious diseases in the country are very costly since virtually almost all of these kits are imported all over the globe. Locally developed and produced nucleic acid-based assays for the diagnosis of life threatening diseases may allow access to this technology even among indigent patients. As an initial project, BIOTECH-MANILA has delved into designing rapid diagnostic tests combining the expertise of the research staff with the latest facilities and equipment available in the country.